Keshen Wang

Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Erratum to "Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer".

Erratum to "Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer".

Journal: Research (Washington, D.C.)
Published: July 22, 2026

Targeting lineage-specific heterogeneity and hypovascular-fibrotic barriers may enable precision immunotherapy in pituitary neuroendocrine tumors.

Targeting lineage-specific heterogeneity and hypovascular-fibrotic barriers may enable precision immunotherapy in pituitary neuroendocrine tumors.

Journal: Frontiers in immunology
Published: January 26, 2026

UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer.

UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 06, 2025

Glymphatic system bridges peripheral and central nervous system changes in classic trigeminal neuralgia.

Glymphatic system bridges peripheral and central nervous system changes in classic trigeminal neuralgia.

Journal: Brain communications
Published: July 22, 2025

USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer.

USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer.

Journal: Cancer research
Published: March 19, 2025

Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer.

Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer.

Journal: Research (Washington, D.C.)
Published: February 26, 2025

Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy.

Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy.

Journal: Molecular carcinogenesis
Published: January 09, 2025

Biological Functions and Therapeutic Potential of UBE2T in Human Cancer.

Biological Functions and Therapeutic Potential of UBE2T in Human Cancer.

Journal: Current cancer drug targets
Published: November 28, 2024

Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG.

Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG.

Journal: Cancer letters
Published: September 25, 2024

Targeting the mevalonate pathway enhances the efficacy of 5-fluorouracil by regulating pyroptosis.

Targeting the mevalonate pathway enhances the efficacy of 5-fluorouracil by regulating pyroptosis.

Journal: Medical oncology (Northwood, London, England)
Published: September 03, 2024

KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC.

KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC.

Journal: Cell reports. Medicine
Published: June 24, 2024

Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study.

Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study.

Journal: Chinese medical journal
Published: May 15, 2024
Showing 1-12 of 20

Last Updated: 09/26/2026